Active ingredient
- glucagon
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet are: PL 04668/0027, PL 04668/0028.
GlucaGen Hypokit 1 mg
Package leaflet: Information for the user
GlucaGen HypoKit 1 mg
Powder and solvent for solution for injection
Glucagon
Read all of this leaflet carefully before you are given this injection because it contains important information for you.
What is in this leaflet
1. What GlucaGen HypoKit is and what it is used for
2. What you need to know before you use GlucaGen HypoKit
3. How to use GlucaGen HypoKit
4. Possible side effects
5. How to store GlucaGen HypoKit
6. Contents of the pack and other information
7. Additional information for medical professionals
1. What GlucaGen HypoKit is and what it is used for
GlucaGen HypoKit contains the active substance “glucagon”.
GlucaGen HypoKit is for immediate, emergency use for children and adults with diabetes who use insulin. It is used when they have passed out (become unconscious) because of very low blood sugar. This is called “severe hypoglycaemia”. GlucaGen HypoKit is used when they are not able to take sugar by mouth.
Glucagon is a natural hormone, which has the opposite effect of insulin in the human body. It helps the liver to change something called “glycogen” into glucose (sugar). Glucose is then released into the blood stream – this makes the blood sugar level rise.
For medical professionals: See section 7.
2. What you need to know before you use GlucaGen HypoKit
Important information
Do not use GlucaGen HypoKit if:
If any of these apply, do not use GlucaGen HypoKit.
Warnings and precautions
Talk to your doctor, pharmacist or nurse before you use GlucaGen HypoKit.
GlucaGen will not work properly if:
If any of these apply, talk to your doctor or pharmacist.
Other medicines and GlucaGen
The following medicines can affect the way GlucaGen HypoKit works:
The following medicines may be affected by GlucaGen HypoKit:
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before having GlucaGen Hypokit.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Pregnancy and breast-feeding
If you experience very low blood sugar, when you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby, you can use GlucaGen HypoKit.
Ask your doctor or pharmacist for advice before taking any medicine, if you are pregnant.
Driving and using machines
Wait until the effects of very low blood sugar have worn off, before driving or using any tools or machines.
GlucaGen contains sodium
GlucaGen contains less than 1mmol sodium (23mg) per maximum dose (2 ml), that is to say essentially ‘sodium-free’.
3. How to use GlucaGen HypoKit
Always use this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Preparing and giving the injection
1. Remove the plastic cap from the vial. Pull the needle cover off the syringe. Do not remove the plastic back-stop from the syringe. Insert the needle through the rubber stopper (within the marked circle) of the vial containing GlucaGen and inject all the liquid from the syringe into the vial.
2. Without taking the needle out of the vial, gently shake the vial until GlucaGen has completely dissolved, and the solution is clear.
3. Make sure the plunger is completely down. While keeping the needle in the liquid, slowly withdraw all the solution back into the syringe. Do not pull the plunger out of the syringe. It is important to remove any air bubbles from the syringe:
Continue to push the plunger until you have the correct dose for injection. A small amount of liquid will be pushed out when you do this.
See How much to use, below.
4. Inject the dose under the skin or into a muscle.
5. Turn the unconscious person on their side to prevent choking.
6. Give the person a high sugar snack like sweets, biscuits or fruit juice as soon as he or she regains consciousness and is able to swallow. The high sugar snack will stop the low blood sugar happening again.
After using GlucaGen HypoKit, you or someone else must contact your doctor or a healthcare provider. You need to find out why you had very low blood sugar and how to avoid it happening again.
How much to use
The recommended dose is:
If you are given more GlucaGen than you should
Too much GlucaGen may lead to nausea and cause you to be sick (vomit). Specific treatment is not usually necessary.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Tell your doctor immediately if you notice any of the following serious side effects:
Very rare: may affect up to 1 in 10,000 people
Other side effects
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Reporting of side effects
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store
5. How to store GlucaGen HypoKit
6. Contents of the pack and other information
What GlucaGen contains
What GlucaGen looks like and contents of the pack
GlucaGen is supplied as a sterile white powder of glucagon in a vial, with a solvent in a disposable syringe. The powder is compacted. Once mixed, the solution contains glucagon 1 mg/ml.
Marketing authorisation holder and manufacturer
7. Additional information for medical professionals
Medical professionals should refer to all sections above before reading this additional information.
Due to the instability of GlucaGen in solution, the product should be given immediately after reconstitution and must not be given as an intravenous infusion.
Do not attempt to put the cap back on the needle of the used syringe. Place the used syringe in the orange box and dispose the used needle in a sharps container at the next available opportunity.
Treatment of severe hypoglycaemia
Administer by subcutaneous or intramuscular injection. If the patient does not respond within 10 minutes, intravenous glucose should be given. When the patient has responded to the treatment, give oral carbohydrate to restore the liver glycogen and prevent relapse of hypoglycaemia.
Diagnostic procedures
Oral carbohydrates should be given when the procedure has ended, if this is compatible with the diagnostic procedure concerned. Remember that GlucaGen has the opposite effect of insulin. With endoscopy or radiography procedures, take extra care in administering GlucaGen to patients with diabetes or to elderly people with a heart condition.
Note that a syringe with a thinner needle and a finer graduation may be more suitable for use in diagnostic procedures.
Examination of the gastrointestinal tract:
Doses vary from 0.2 – 2 mg depending on the diagnostic technique used and the route of administration. The diagnostic dose for relaxation of the stomach, duodenal bulb, duodenum and small bowel is 0.2 – 0.5 mg given intravenously or 1 mg given intramuscularly. The dose to relax the colon is 0.5 – 0.75 mg intravenously or 1 – 2 mg intramuscularly. The onset of effect after an intravenous injection of 0.2 – 0.5 mg occurs within one minute and the duration of the effect is between 5 – 20 minutes. The onset of action after an intramuscular injection of 1 – 2 mg occurs after 5 – 15 minutes and lasts approximately 10 – 40 minutes.
Additional side effects after use in diagnostic procedures
Blood pressure changes, rapid heartbeat, hypoglycaemia and hypoglycaemic coma.
This leaflet was last revised in 05/2021
GlucaGen® is a trademark owned by Novo Nordisk A/S, Denmark
© 2021
Novo Nordisk A/S
3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA
+44 (0)1293 613555
+44 (0)800 023 2573
+44 (0)800 023 2573
+44 (0)1293 613535